High-definition Transcranial Direct Current Stimulation Impact on Associative Memory during Slow-wave Sleep
This study uses high-definition transcranial direct current stimulation to examine its impact on associative memory during slow-wave sleep in healthy adults.
high-definition transcranial direct current stimulation (HD-tDCS)
+ sham high-definition transcranial direct current stimulation (HD-tDCS)
Services Research Study
Summary
Study start date: January 12, 2022
Actual date on which the first participant was enrolled.This study aims to explore how stimulating the brain during sleep might improve memory in healthy adults. Participants are divided into three groups: one that will receive brain stimulation during deep sleep, one that will take a nap without real stimulation, and another that will receive stimulation while awake. The device used is called high-definition transcranial direct current stimulation (HD-tDCS), and it targets a specific brain area linked to memory. This research is important because it could lead to new ways to enhance memory, which might be beneficial for learning and cognitive health. Participants will have electrodes placed on their scalp, specifically targeting the left side of the brain, as well as other areas for the stimulation process. They will perform memory tasks like the face-word associative memory task before and after the nap or wake period to assess any changes in memory performance. The study will evaluate the effects of both real and placebo (sham) stimulation to determine its true impact. There are no specific risks mentioned, but the study helps in understanding how safe and effective this brain stimulation is for improving memory.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.87 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Services Research Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 30 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.3 intervention groups are designated in this study
66.667% chance of being blinded to the placebo group
Treatment Groups
Group I
Active ComparatorGroup II
ShamGroup III
PlaceboStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location